This interactive session will review common questions that come up in primary care through a wheel game format. Faculty will cover a variety of topics including obstructive sleep apnea, thyroid disease, LGBTQ health, dizziness, adolescent health, as well as current hot topics in medicine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/8/2020, and they are subject to change as new information is published.

This session covers a variety of recent publications that contradict many of the current eating trends and fads in western diets. Debunking the hype and assumption that the internet and many advertisements tell our patients is the focus. The session ends with a simple 5 step process to help all patients who want to lose weight.

This session will provide primary care clinicians with a foundational understanding of the pathophysiology of obesity. We will review the 4-pillar concept of obesity treatment and provide practical skills for applying nutritional interventions, physical activity recommendations, behavioral therapy approaches, and medication treatments for patients with obesity.

When should you recommend Vitamin D to your patients? Based on the latest evidence, which conditions does Vitamin D supplementation help and which does it hinder? Tune in as Dr. Frank Domino sheds some much-needed light on a topic that continues to perplex patients and clinicians alike.

Over ten percent of the U.S. population suffers disproportionate cardiometabolic risk because of their type 2 diabetes (T2DM). In light of recent data, GLP-1 receptor agonists (GLP-1 RAs) have taken on a more prominent role in T2DM management algorithms. This session will discuss how you can distinguish among GLP-1 RAs and use them in your practice to help manage the risks that these patients face beyond glucose control. A member of the Diabetes Sisters organization will also be joining us to discuss their experience with starting a GLP-1 RA as a patient.

Join Dr. Sanjiv Chopra, hepatologist, author, speaker, and thought leader as he interviews his guest, Dr. Martin Abrahamson, endocrinologist and associate professor at Harvard Medical School as they discuss major advances in diabetes as well as the promise of stem cell treatment, diet and weight loss in patients with diabetes, and advances in continuous glucose monitoring. The pair will end their conversation discussing what they have learned from patients over the years.

An elevated fasting blood glucose (FBG) is the hall mark of prediabetes. Fasting blood glucose increases approximately 1 mg/dl per year as a prediabetic. While it can take years for a person to develop type 2 diabetes from prediabetes, weight gain, sedentary lifestyle, illness, or stress, can accelerate this process. This presentation will discuss the prevalence and progression of prediabetes, as well as the most effective strategies to prevent the development of type 2 diabetes.

Adults with type 2 diabetes mellitus (T2DM) have a two- to four-fold increase in risk for cardiovascular (CV) morbidity and mortality. This session cuts to the heart of primary and secondary prevention in this population, presenting recent data on antihyperglycemic medications with proven cardiovascular benefit in the context of updated management algorithms. Individualized treatment is critical to the success of these treatment plans. The faculty will help you optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/26/2020, and they are subject to change as new information is published.

Adults with type 2 diabetes mellitus (T2DM) have a two- to four-fold increase in risk for cardiovascular (CV) morbidity and mortality. This session cuts to the heart of primary and secondary prevention in this population, presenting recent data on antihyperglycemic medications with proven cardiovascular benefit in the context of updated management algorithms. Individualized treatment is critical to the success of these treatment plans. The faculty will help you optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/26/2020, and they are subject to change as new information is published.

There are emerging epidemics of obesity, metabolic syndrome, and type 2 diabetes mellitus in the U.S. and around the world. In this session, you will receive valuable pharmacological and non-pharmacological tools to combat these conditions in the primary care setting. The faculty will share their experience in providing care with a multidisciplinary team, use of meal replacements, and personalized weight loss plans based on body composition and lifestyle.

Obesity is the most prevalent chronic disease of the modern era in the U.S. and around the world, affecting both the adult and pediatric population. Although many believe that helping patients to achieve a healthy weight is of minimal complexity, weight regulation and management is a challenging endeavor. In this talk, the faculty will explore the complexities of obesity and offer a range of strategies (behavioral, therapeutic, and surgical) to help you in the quest to address overweight and obesity in your practice.

This talk will provide an evidence-based approach to the detection, treatment, and monitoring of osteoporosis. Important, recently published studies will be referenced. You will walk away more informed about controversies on how long to treat and current estimates of the rates of adverse effects of therapy.